These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
97 related articles for article (PubMed ID: 7036244)
21. Grand Rounds: Adjuvant therapy of breast cancer. Va Med; 1977 Oct; 104(10):709-15. PubMed ID: 919723 [No Abstract] [Full Text] [Related]
22. Randomized comparison of two combination chemotherapy regimens containing doxorubicin in patients with metastatic breast cancer: a Western Cancer Study Group trial. Irwin LE; Chlebowski RT; Weiner JM; Reynolds R; Pugh RP; Ryden VM; Bateman JR Cancer Treat Rep; 1980; 64(8-9):981-4. PubMed ID: 7004635 [TBL] [Abstract][Full Text] [Related]
23. Combination of levamisole immunotherapy and polychemotherapy in advanced breast cancer. Klefström P Cancer Treat Rep; 1980 Jan; 64(1):65-72. PubMed ID: 6991105 [TBL] [Abstract][Full Text] [Related]
24. Combination chemotherapy in advanced breast cancer. A report of the Working Party of the Multicentre Cancer Chemotherapy Group. Spittle MF; Bates TD; Kitchen G; Nicol NT; Wheeler T; Edelstyn G; MacRae KD; Ostrowski MJ Clin Oncol; 1980 Jun; 6(2):153-7. PubMed ID: 7408282 [No Abstract] [Full Text] [Related]
25. [Effect of antiblastic polychemotherapy (CMF) on the number of circulating monocytes in patients with breast cancer]. Bariani L; Dolcetti U; Indelli M; Gualandi G; Malacarne P; Castaldi G Minerva Med; 1982 Oct; 73(39):2641-8. PubMed ID: 7121879 [TBL] [Abstract][Full Text] [Related]
26. Occasional notes. The management of early breast cancer. Canellos GP; Hellman S; Veronesi U N Engl J Med; 1982 Jun; 306(23):1430-2. PubMed ID: 7043266 [No Abstract] [Full Text] [Related]
27. [Chemotherapy of advanced breast cancer--actual results ]. Matthes ML; Lenk H; Gürtler R; Tanneberger S Arch Geschwulstforsch; 1982 May; 52(3):241-6. PubMed ID: 6812538 [TBL] [Abstract][Full Text] [Related]
28. Actual data on efficacy of surgical adjuvant chemotherapy with CMF in breast cancer. Bonadonna G; Rossi A; Valagussa P; Veronesi U Arch Geschwulstforsch; 1978; 48(7):659. PubMed ID: 736746 [No Abstract] [Full Text] [Related]
29. [Polychemotherapy of advanced cancer of the breast]. Mascia V; Massidda B; Pellegrini A Minerva Med; 1978 May; 69(26):1803-8. PubMed ID: 662182 [TBL] [Abstract][Full Text] [Related]
30. Results of a randomized trial of prophylactic chemotherapy in T3-T4 breast cancer patients previously treated by radiotherapy. Serrou B; Sancho-Garnier H; Cappelaere P; Plagne R; Metz R; Schneider M; Chollet P; Namer M; Pujol H; Gary-Bobo J; Meyer G; Mathé G Recent Results Cancer Res; 1978; 68():105-8. PubMed ID: 752850 [No Abstract] [Full Text] [Related]
31. Chemoimmunotherapy for metastatic breast cancer with 5-fluorouracil, adriamycin, cyclophosphamide, methotrexate, L-asparaginase, Corynebacterium parvum, and Pseudomonas vaccine. Hortobagyi GN; Yap HY; Wiseman CL; Blumenschein GR; Buzdar AU; Legha SS; Gutterman JU; Hersh EM; Bodey GP Cancer Treat Rep; 1980 Jan; 64(1):157-9. PubMed ID: 6991103 [TBL] [Abstract][Full Text] [Related]
32. Controlled prospective trial of combination chemotherapy with cyclophosphamide, adriamycin, and 5-fluorouracil for the treatment of advanced ovarian cancer: a preliminary report. Bruckner HW; Pagano M; Falkson G; Creech R; Arseneau JC; Horton J; Brodovsky H; Davis TE; Slayton RW; Greenspan E Cancer Treat Rep; 1979 Feb; 63(2):297-9. PubMed ID: 376136 [No Abstract] [Full Text] [Related]
34. Re: International guidelines for management of metastatic breast cancer: combination vs sequential single-agent chemotherapy. Chlebowski RT J Natl Cancer Inst; 2010 Jan; 102(2):137. PubMed ID: 20019336 [No Abstract] [Full Text] [Related]
35. Swiss adjuvant trial (OSAKO 06/74) with chlorambucil, methotrexate, and 5-fluorouracil plus BCG in node-negative breast cancer patients: nine-year results. Senn HJ; Jungi WF; Amgwerd R; Hochuli E; Ammann J; Engelhart G; Heinz C; Wick A; Enderlin F; Creux G NCI Monogr; 1986; (1):129-34. PubMed ID: 3534585 [TBL] [Abstract][Full Text] [Related]
36. [Disseminated breast carcinoma. Study of activity of immunotherapy with BCG and duration of the phase of intensive chemotherapy. Results of a randomized trial (author's transl)]. Pouillart P; Palangie T; Jouve M; Garcia-Giralt E; Magdelenat H; Asselain B Bull Cancer; 1981; 68(1):6-18. PubMed ID: 7013868 [TBL] [Abstract][Full Text] [Related]
37. Adjuvant chemotherapy, anti-estrogen therapy and immunotherapy for stage II breast cancer. Hubay CA; Pearson OH; Marshall JS; Rhodes RS; Debanne SM; Mansour EG; Hermann RE; Jones JC; Flynn WJ; Eckert C; McGuire WL Eur J Cancer (1965); 1980; Suppl 1():189-95. PubMed ID: 7032932 [No Abstract] [Full Text] [Related]
38. [The chemotherapy of advanced breast cancer. A report on the first 600 cases in a cooperative programme to carry out a systematic study (1974-1977) (author's transl)]. Chauvergne J; Durand M; Berlie J J Gynecol Obstet Biol Reprod (Paris); 1978; 7(4):877-86. PubMed ID: 361799 [TBL] [Abstract][Full Text] [Related]
39. Chemotherapy of metastatic breast cancer in postmenopausal women: a controlled trial of cyclophosphamide versus a five-drug combination of cyclophosphamide, vincristine, methotrexate, 5-fluorouracil and prednisone. Mouridsen HT; Palshof T Prog Clin Biol Res; 1977; 12():459-66. PubMed ID: 335404 [No Abstract] [Full Text] [Related]
40. Preliminary Results of trials of chemotherapy in advanced ovarian carcinoma. Young RC; Chabner BA; Hubbard SP; Canellos GP; DeVita VT Natl Cancer Inst Monogr; 1975 Oct; 42():145-8. PubMed ID: 825777 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]